These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8552331)

  • 1. Sotalol. New weapon against ventricular arrhythmias.
    Holcomb SS
    Nursing; 1995 Dec; 25(12):24O-24P, 24R. PubMed ID: 8552331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias.
    Reiffel JA
    Am Heart J; 1999 Feb; 137(2):372-3. PubMed ID: 10049191
    [No Abstract]   [Full Text] [Related]  

  • 4. Sotalol for cardiac arrhythmias.
    Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does sotalol have reverse-use dependence during tachyarrhythmias?
    Kovoor P; Byth K; Uther JB; Ross DL
    Am J Cardiol; 1996 Jul; 78(2):247-50. PubMed ID: 8712156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 10. Procainamide: Test your drug IQ.
    Gever MP
    Nursing; 2006; 36(5 Suppl E D):25. PubMed ID: 16641699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.
    Saul JP; Ross B; Schaffer MS; Beerman L; Melikian AP; Shi J; Williams J; Barbey JT; Jin J; Hinderling PH;
    Clin Pharmacol Ther; 2001 Mar; 69(3):145-57. PubMed ID: 11240979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol in Life-Threatening Ventricular Arrhythmias: A Unique Class III Antiarrhythmic. Symposium proceedings. Phoenix, Arizona, September 19-22, 1991.
    Am J Cardiol; 1993 Aug; 72(4):1A-85A. PubMed ID: 8102220
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic management of arrhythmias.
    Bink-Boelkens MT
    Pediatr Cardiol; 2000; 21(6):508-15. PubMed ID: 11050274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of Sotalol (Darob) therapy in ventricular arrhythmias.
    Toporan D; Stancu M; Glodan D
    Rom J Intern Med; 1999; 37(1):31-41. PubMed ID: 15523943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
    Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    Am J Cardiol; 1996 May; 77(11):1004-8. PubMed ID: 8644624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sotalol on RR interval variability during induced ventricular tachycardia.
    Yli-Mäyry S; García-Alberola A; Haverkamp W; Hindricks G; Martínez-Rubio A; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Aug; 78(3):372-6. PubMed ID: 8759826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ
    Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
    [No Abstract]   [Full Text] [Related]  

  • 18. Sotalol: a rescue drug in the face of life-threatening refractory ventricular tachycardia.
    Kandasamy A; Arumugham S; Krupanandha H; Reddy B
    Ann Card Anaesth; 2014; 17(2):170-2. PubMed ID: 24732625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and efficacy testing of sotalol.
    Mason JW
    J Am Coll Cardiol; 1999 Jan; 33(1):53-4. PubMed ID: 9935008
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
    Cohen MB; Snow JS; Merkatz KA; Kholwadwala D; Jadonath RL; Goldner BG; Cohen TJ
    Am Heart J; 1996 Aug; 132(2 Pt 1):446-9. PubMed ID: 8701909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.